Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1103 of 5804
-
New eye drop could ease severe allergy symptoms in kids and adults
Disease control Recruiting nowThe aim of the study is to investigate whether patients with moderate-to-severe VKC and keratitis will benefit from the addition of Diquafosol ophthalmic solution in terms of symptoms and signs of VKC, tear film metrics, ocular surface inflammation and quality of life. Potential …
Phase: PHASE3 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New shot aims to keep depression away longer
Disease control Recruiting nowThis study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying the return of major depressive symptoms. The trial is divided into three periods as follows: a screening period that will last appro…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for bladder cancer: experimental drug joins standard combo
Disease control Recruiting nowResearchers are looking for new ways to treat people with urothelial cancer (UC) that is locally advanced or metastatic. The standard treatment for locally advanced or metastatic UC is enfortumab vedotin (EV) given with pembrolizumab. The goals of this study are to learn about: …
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could peer buddies and shots keep teens with HIV healthy?
Disease control Recruiting nowThis is a 2-stage study assessing the effect of peer navigation (support from peers) and long-acting injectable antiretroviral therapy (ART) on viral suppression and retention in care among adolescents living with HIV and receiving care in South Africa.
Phase: NA • Sponsor: Africa Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Herbal granules aim to stop AFib recurrence after heart procedure
Disease control Recruiting nowThe goal of this clinical trial is to investigate the efficacy and safety of Qidong Yixin Granules in preventing recurrence in patients after radiofrequency catheter ablation for atrial fibrillation. The main question it aims to answer is: Can Qidong Yixin Granules reduce the re…
Phase: PHASE4 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Man's best friend as therapy: dog training program tested for Veterans' PTSD
Symptom relief Recruiting nowThe goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in \[describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers\]. The main questions it aims to answer a…
Phase: NA • Sponsor: Florida Atlantic University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New app and urine test aim to boost HIV med adherence in men who use stimulants
Disease control Recruiting nowMen who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Long COVID secrets revealed? 4-Year study tracks 400 patients
Knowledge-focused Recruiting nowLong COVID (persistent COVID) represents a major global health challenge due to its high prevalence (approximately 7%), significant impact on quality of life, and socioeconomic burden. Despite extensive research, diagnostic tools to objectively identify or predict long COVID evol…
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Heart pouch plug may cut stroke risk for AFib patients who Can't take blood thinners
Disease control Not yet recruitingThis study aims to evaluate the endotheliation efficacy of the AnchorMane® Left Atrial Appendage Occluder in non-valvular atrial fibrillation patients at high stroke risk. It investigates the rate of complete endotheliation of the occluder at 6 months post-procedure using routine…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Balloon over stent? new heart attack treatment tested
Disease control Recruiting nowDrug-eluting stent (DES)-based primary percutaneous intervention (pPCI) has been established as the standard of care for patients presenting with ST-segment elevation myocardial infarction (STEMI), having demonstrated superiority over thrombolysis, plain balloon angioplasty, and …
Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Which hamstring workout best prevents injuries in pro footballers?
Prevention OngoingFootball is a sport with a high risk of injury, and hamstring muscle injuries are among the most common problems faced by players. These injuries can reduce a player's performance, cause time away from training and matches, and place a burden on medical teams and clubs. Many trai…
Phase: NA • Sponsor: Emirates Health Services (EHS) • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
New hope for tough cancers: experimental drug IPN01203 enters human trials
Disease control Recruiting nowThe purpose of this study is to determine the appropriate dosage, safety and effectiveness of a new drug, IPN01203, in adults with advanced solid tumours. Advanced solid tumours are cancers that can occur in various organs or tissues and have spread from their original site to n…
Phase: PHASE1, PHASE2 • Sponsor: Ipsen • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New app aims to ease lung cancer Survivors' struggles with breathing and daily activities
Symptom relief Recruiting nowThe rationale for the proposed project is to improve the experience and outcomes of individuals diagnosed with lung cancer treated for cure. Survival rates in patients with stages I-III lung cancer continue to increase given progress in early detection and more effective treatmen…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New drug PLB-002 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study will test the safety, including side effects, and determine the characteristics of a drug called PLB-002 in participants with solid tumors.
Phase: PHASE1 • Sponsor: Primelink BioTherapeitics(ShenZhen) Limited • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New Two-Drug attack on Hard-to-Treat myeloma enters early human tests
Disease control Recruiting nowThe main purpose of the study is to understand the safety and tolerability of cemsidomide when given along with elranatamab in subjects with relapsed or refractory multiple myeloma. The first part of the study will evaluate different dose levels of cemsidomide in combination wit…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New pill could tame involuntary twitching in mental health patients
Symptom relief Recruiting nowThe primary objective of this study is to evaluate the efficacy of NBI-1065890 compared with placebo for the treatment of tardive dyskinesia (TD) in adult participants.
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New drug shows promise for rare high cholesterol condition
Disease control Recruiting nowEDP167 is a double-stranded small interfering RNA (siRNA) drug targeting angiopoietin-like 3 protein (ANGPTL3), which may bring benefits for patients with dyslipidemia conditions. This is a dose exploration study in Homozygous Familial Hypercholesterolaemia (HoFH) patients to eva…
Phase: PHASE2 • Sponsor: Eddingpharm (Zhuhai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Laser zaps brain tumor regrowth without delaying key therapy
Disease control Recruiting nowGlioblastoma (GBM) remains aggressive despite standard therapy (surgery (CRET) + RT/CT). Over 40% of patients develop recurrence between surgery and pre-RT MRI, with median overall survival (OS) of 13.3m and 24.4m for patients with and without recurrence in pre-RT MRI, respective…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Video coaching from home: a new approach to help preterm babies catch up on motor skills
Disease control OngoingPreterm infants are at increased risk for developmental delays, making early intervention essential for optimizing developmental outcomes. This study aims to evaluate the effectiveness of the Homeostasis-Enrichment-Plasticity (HEP®) approach delivered via telerehabilitation in pr…
Phase: NA • Sponsor: Medipol University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Brain training before amputation may stop phantom pain
Prevention ENROLLING_BY_INVITATIONThis prospective study seeks to evaluate the effectiveness of prophylactic Targeted Brain Rehabilitation (TBR) in preventing or reducing Phantom Limb Pain (PLP).
Phase: NA • Sponsor: OrthoCarolina Research Institute, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC